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In a assay published in Nature, Valentin Amrhein 
(University of Basel) and its colleagues Sander 
Greenland (University of California) & Blake McShane 
(Northwestern University), present a series of 
arguments against the stablished “P value-based 
statistical significance dichotomania”.1 The authors 
use some insightful practical examples, such as data 
related to unintended effects of anti-inflammatory 
drugs risks, and consider the influence of human 
cognitive trend to simplistically bucket results into 
“statistically significant” and “statistically non-
significant” categories and to consider it definitely 
different. 
Importantly, the essay clearly states that the 
authors are not advocating a ban on P values or 
statistical measures, but that P values should not be 
treated categorically or to support dichotomization 
as statistically significant or not. Similarly, a 2016’ 
statement of the American Statistical Association2 
warns against the misuse of statistical significance 
and P values, which include as a recommendation 
“don’t say statistically significant”. On the other hand, 
John P. A. Ioannidis (Stanford University), argue that 
“retiring statistical significance would give bias a free 
pass’ and that ‘irrefutable nonsense would rule’”.3 The 
author states that dichotomous conclusions can be 
useful for pinning down discoveries in different fields, 
but the analysis of effect sizes “can often be better 
than determining whether an effect exists”.
While such discussion is at least provoking and mind 
challenging, this Editorial goal is to take advantage of 
the “statistical dogma” questioning to draw some 
attention to steps that precede the statistical analysis 
and the generation of a given P value. Indeed, a 
proper study design can even improve the statistical 
findings power in a measurable way, but also several 
aspects of study design and the subsequent data 
analysis may have a significant (forget P values for 
a moment), but not statistically quantifiable, impact 
in the data “significance”. The big mistake would be 
the overvaluation of statistical analysis methods with 
the undervaluation of experimental design. In the 
sequence, some practical examples (derived from 
our research group data) will be used to illustrate 
how study design can increase the both “statistical 
significance” and “biological significance”. 
Genetic studies are usually based in a classic 
control approach, were controls and subjects 
presenting a given condition are compared in 
regards of the occurrence and frequency of genetic 
variants. In this context, the P value derived from 
the unaffected and affected individuals’ comparison 
is essential to draw any conclusion. In such studies, 
the number of individual in such groups, but also 
the frequency of the target genetic variation, the 
frequency of the studied condition, impact the study 
power and the determination of the P value, and 
evidently, the conclusions derived from such data. 
However, experimental design features, apparently 
incomputable in the study power determination, 
can also present a significant impact in the analysis 
outcome. Thus, in this situation, stratified sampling 
considering these possible confounding factors could 
balance the study groups and minimize the effect of 
external variables on the final data analysis.
In the periodontal genetic studies, generally 
affected individuals (presenting some form of 
periodontitis) are compared with periodontally healthy 
subjects.4-7 However, in this context, the possibility to 
control microbial exposure by oral hygiene methods 
interfere with the exposure factor, and consequently 
a periodontally healthy population is comprised by 
subjects that properly perform oral hygiene methods 
as a routine. Therefore, irrespective of the putative 
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susceptible and resistant genotypic nature, such 
subjects will not develop the disease phenotype due 
the proper oral care. Indeed, such unique feature 
clearly differ from the usual characteristics of 
infectious diseases genetic studies, where affected 
and unaffected individuals are typically recruited from 
endemic areas where groups are naturally exposed 
to a pathogenic challenge, and the resistant and 
susceptible phenotypes are consequently exposed.8,9 
Therefore, the absence of the microbial factor in a 
periodontally healthy population, clearly disregard the 
case-control study architype, which determine if an 
exposure is associated with an outcome.8,9
In other words, the absence of an archetypical 
control with a defined resistance phenotype may limit 
the odds of the identification of genotypic differences 
when compared with a susceptible group. In order to 
adapt the study design to the exposure concept, in 
periodontitis genetic studies the control group should 
comprise a microbially exposed group with a distinct 
phenotypic outcome than chronic periodontitis.10 Such 
features can be found in individuals presenting chronic 
gingivitis, characteristically exposed to a periodontal 
microbial challenge associated with a reversible low 
severity disease form characterized by the absence of 
attachment, which in theory, represent “resistance” 
phenotype/genotype. Indeed, the “resistant versus 
susceptible” phenotype analysis, when compared to 
the traditional “healthy versus diseased” approach, 
significantly impacted the study power and odds of 
identification of genetic factors involved in PD.10 The 
overall impact in the study power was the boost to 
>85% of a previous <30% power, while the overall odds 
ratio values seems to double in this approach; being 
such impact derived from the proper observation of 
the archetypical study design, supported by exposure-
based phenotypes determination, comprehensively 
used in infectious diseases genetic studies. 
Phenotypic variation can also be a supporting 
factor for data analysis and interpretation in order to 
determine the possible involvement of a given factor 
in a pathological process. Still in periodontitis context, 
molecules that control osteoclastogenesis process have 
been regarded as potential determinants of disease 
onset, progression and severity. In this framework, 
the osteoclastogenic factor RANKL and its endogenous 
inhibitor OPG, have been in the focus of numerous 
studies in the field over the last years.11 Briefly, 
RANKL levels are supposed to be locally upregulated 
by chronic inflammatory immune response elements, 
leading to the bone resorption that characterizes 
periodontitis, while anti-inflammatory mediators 
present a counteracting effect via OPG upregulation. 
A common approach in host factors focused studies is 
to comparatively measure the coding mRNA or protein 
levels, or to perform the staining of cells positive for 
such targets, in diseased and healthy tissues. However, 
such approach can be also limiting in terms of data 
Figure 1- Exposure factor vs phenotype/genotype determination
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interpretation and “biological significance” by the 
reasons similar to those highlighted for the genetic 
studies. 
A healthy tissue represents homeostasis and a 
diseased tissue represents pathology. However, both 
allegedly destructive (RANKL) and protective (OPG) 
factors are upregulated in diseased tissues, similarly 
to numerous inflammatory and also anti-inflammatory 
mediators.11,12 Indeed, one could argue how increased 
levels of anti-inflammatory and anti-osteoclastogenic 
factors, associated to “highly significative” P values 
(in healthy vs diseased tissues comparison), are 
presented in inflamed and diseased periodontal sites? 
It is also important to consider that if a given molecule, 
with unknown role, would identified as upregulated in 
diseased periodontal tissue, the immediate assumption 
regarding its role in the disease pathogenesis probably 
will be to label such molecule as “destructive”.
In this scenario, the use of additional distinct and 
phenotypes can allow additional data analysis and 
provide some insightful information about how host 
inflammatory immune response mediators can impact 
periodontitis outcome. One possible approach is to 
compare periodontitis variants, such as aggressive and 
chronic, each one characterized by its unique features, 
such as early vs late onset and different progression 
rates.12 In such comparison, it is possible to observe 
variations in RANKL/OPG ratio, which can explain the 
possible variations between the forms, but the sole 
comparison of each form with healthy tissue would 
not allow such inference, despite the “very significant” 
P value, “more significant” than the aggressive vs 
chronic comparison. Importantly, the comparison on 
distinct disease forms points to a differential balance 
in the levels of pro- vs anti-osteoclastogenic and 
pro- vs anti-inflammatory mediators as determinants 
of disease outcome. However, the determination of 
the “tipping point” that separates homeostasis from 
pathology may require additional approaches, which 
will be explored further below.
One may argue that phenotypic variation may not 
be necessary, since it would be possible to perform 
some severity disease stratification within an individual 
disease form, based in clinical readouts such as 
bleeding on probing, probing depth and attachment 
loss. However, it is mandatory to consider the intrinsic 
limitations imposed by periodontitis features, which 
include the cumulative nature of disease severity, and 
the uncertainness about disease progression patterns, 
impose critical limitations to data interpretation.13,14 
Importantly, the definition of active bone resorption 
is quite complex in periodontitis, which seems 
to progress via active disease bursts followed by 
quiescent periods, being the current clinical tools 
ineffective in the determination of the actual status 
of disease during the analysis/sampling, and even 
to determine the progression model.11,14 Indeed, a 9 
mm deep periodontal pocket in a supposed stable/
remission state can present distinct features of a 4 
mm deep conjectural active site. Indeed, in general, 
“immediate” parameters such as bleeding on probing 
and/or probing depth have been found to not be 
directly correlated with cytokines, irrespectively of its 
pro-inflammatory (where a positive correlation could 
be expected) and/or with anti-inflammatory features 
(where a negative correlation could be expected).15-18 
A similar picture can be observed in periapical lesions, 
where the lesion size does not necessarily correlates 
with a “higher” activity signature (i.e. expression of 
tissue destructive mediators) than smaller lesions (at 
the moment of sample collection).19-22 
Therefore, the comparison of periodontitis-derived 
data with other conditions can also support better 
interpretation of RANKL/OPG ratio association with 
active or inactive bone resorption. While the definition 
of active bone resorption is complex in periodontitis, in 
orthodontic tooth movement such patterns are more 
straightforwardly distinguishable.23-25 Categorically, 
the bone resorption activity is a hallmark of pressure 
side, and can be comparatively analyzed in the tension 
side counterpart, where the bone formation activity 
prevail.26-28 Such data can provide a theoretical cutoff 
or threshold value that distinguish presence of absence 
of active bone resorption, which can be applied 
to periodontitis or other inflammatory osteolytic 
conditions, such as periapical lesions, to support 
additional analysis or assumptions.22,29,30
In an additional example on how the use of distinct 
phenotypes can provide “biological significance” that 
can overcome “statistical significance” in providing 
data interpretation support, let’s consider that a 
family of molecules, collectively called SOCS. SOCS 
are intracellular proteins that acts as suppressors of 
inflammatory cytokine signaling, and therefore, are 
putatively involved in the control of inflammatory 
response in periodontitis, which ultimately interfere in 
the RANKL/OPG ratio modulation and in the disease 
outcome.21,31 A study demonstrate that SOCS levels are 
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upregulated in diseased tissues when compared with 
healthy ones, associated with a “very significative” P 
value (P<0.001).32 Similarly to previously mentioned 
to OPG and anti-inflammatory mediators, one 
could argue how increased levels of inflammation 
suppressors, associated to “highly significative” P 
values (in healthy vs diseased tissues comparison), 
are presented in inflamed and diseased periodontal 
sites? However, such study also demonstrates that 
SOCS levels are higher in chronic gingivitis than in 
chronic periodontitis, which provides some interesting 
additional biological clue, but such association 
present a “less significative” P value (P<0.05) than 
the healthy vs diseased approach.32 Based in the 
initial comparison, it is possible to recognize that 
SOCS are generally absent in healthy tissues being 
upregulated in response to inflammation. However, 
the second scenario allow us to infer that a more 
pronounced upregulation in chronic gingivitis could 
suggest a more efficient suppressive feedback, which 
could account for some phenotypic variation between 
gingivitis and periodontitis. Even considering that 
the P value from “healthy vs diseased” analysis 
(P<0.001) is higher than in the “phenotypic variation” 
comparison (P<0.05), the second comparison may 
be biologically “more significant” or more relevant 
for data interpretation.32 It is also important to note 
that oftentimes, a result that indicates statistically 
significant differences has little or no biological impact. 
Therefore, it is essential that the researcher knows that 
although methodologically important in study, above 
the statistics should be his biological knowledge and 
interpretation about the results. In this context, it is 
possible to consider that the “biological significance” 
can overcome the “statistical significance” in providing 
support the data interpretation, allowing a broader 
picture of the immunoregulatory scenario. 
Indeed, the analysis of data generated from 
“phenotypic variation” other than the simple “healthy 
vs diseased” dichotomy allows a series of correlation 
analysis that would result in false positive results in 
the “healthy vs diseased” analysis. Please remember 
that diseased periodontal tissues are characterized by 
high levels of theoretically destructive elements, such 
as osteoclastogenic factors (including RANKL) and 
pro-inflammatory molecules, but also for high levels 
of supposedly protective elements, such as OPG and 
anti-inflammatory molecules (such as IL-10), when 
compared to healthy tissues. Since a high variation 
in the levels of such molecules is present between 
health and disease conditions, correlation analysis 
including samples from both groups presents a high 
trend to biased “false correlations”.21,32 It is known 
from experimental studies (whose importance will be 
considered in the sequence) that IL-10 induces OPG 
upregulation and RANKL downregulation. However, a 
”healthy vs diseased” correlation analysis can result 
in positive correlations between IL-10 and OPG, but 
also between IL-10 and RANKL, with “very significative 
R and P values” (unpublished data). When such 
correlation is performed observing the “phenotypic 
variation”, or performed only with a single disease from 
samples, the positive correlation between IL-10 and 
OPG is sustained, but with “less significative R and P 
values”. Additionally, such analysis also reveals that IL-
10 and RANKL are non-correlated, being RANKL levels 
actually correlated with pro-inflammatory mediators 
(unpublished data); being this data in accordance 
with IL-10 properties previously mentioned.21,32 Also, 
similar patterns (positive correlations between IL-10 
and OPG) were observed when lesions are stratified 
as theoretically active of inactive based in RANKL/
OPG threshold, being IL-10 and OPG expression 
predominant in inactive lesions.22,29,30,33
Moreover, when biological events are evaluated 
such as those mentioned above, it may be naive to 
trust that a single independent variable would be 
responsible for the outcome response evaluated. 
Correlation analyzes may present significant p 
values between OPG/RANKL with IL-10, but most 
likely are not the only factors influencing the such 
ratio values. Therefore, any consideration about the 
subject that is not based on a broader spectrum of 
possible influencing factors (independent variables) 
is naturally weakened, even if based on significant p 
values. Thus, for biological analyzes involving complex 
mechanisms, multiple regression models (linear, 
logistic, Poisson, etc.) could be extremely useful in 
assessing the impact of a number of independent 
variables, such as age, gender, ethnicity, oral hygiene, 
specific clinical variables, presence or absence (and 
quantity) of a series of inflammatory mediators and 
pathogenic microorganisms, genetic variants, among 
others in the analysis of a simple outcome such as 
having or not having the disease. However, due to 
the biological complexity involved in this example, 
the list of independent variables could be infinite if it 
had no methodological impact either. For regression 
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models to be robust in data analysis, for each 
independent variable included in the research, in a 
very simplistic way, 10 to 15 sample units (animals, 
patients, etc.) should ideally be included in the study. 
However, in some cases this theory may be beautiful 
on paper but impossible in practice as it could make 
a methodologically unviable study due to the large 
minimum sample size required. 
Also, it is mandatory to consider that dichotomization 
or comparisons based in phenotypic data completely 
differ from dichotomization or stratification based in 
random scores frequently attribute to the analysis 
process. Indeed, it is common to receive in JAOS the 
submission of papers comprising the use of percentage 
scores, derived from the quantification of cells 
positively stained for a given target, such as RANKL. 
In this virtual scenario (roughly based in submitted 
papers), score zero refers to 0 to 5% of stained cells, 
score one refers to 5 to 25%, score two to 26 to 50%, 
and so on. Therefore, a 25% sample and a 26% sample 
would receive different scores, while 26% and 50% 
samples would receive the very same score. It seems 
that it is not necessary to apply complex statistical 
tools to realize that some qualitative ‘downgrade’ 
may not be the best option for the subsequent data 
analysis, especially when the quantitative data is 
available. This strategy leads to a weakening of the 
dependent variable and consequently a less robust 
and accurate data analysis. When the stratification 
is necessary, and phenotypic data is not available to 
guide the stratification, the use of tertiles, quartiles, 
deciles or cluster analysis can be more adequate than 
the random assignment of samples into scores or 
subgroups. Indeed, a cluster analysis demonstrated 
that the clustering of osteolytic periapical lesions was 
primarily based in RANKL/OPG,29 presenting a high 
match (>90%) with the inactive/inactive classification 
based in pressure/tension RANKL/OPG threshold. 
Additionally, the stratification of the lesions based in 
RANKL/OPG tertiles reveals a very high match between 
the high RANKL/OPG tertile and the theoretically active 
lesions.30 At this point, is also mandatory to consider 
that the use of multiple analysis models can also 
reinforce the strength of the data, despite the lack of 
direct influence in P values of independent analysis.
Another non-mathematical tool that can be 
supporting factor for increasing data strength refers to 
the combination of different approaches in the study 
design, such as combining clinical and experimental 
data. Return to the unclear nature of bone activity 
or inactivity in periodontitis, and the possibility of 
determine a theoretical threshold value that distinguish 
presence of absence of active bone resorption based 
in tension/pressure sides of orthodontic movement. 
Despite comprising and valid and interesting approach, 
one may argue that orthodontic tooth movement 
features may be not applied to periodontal disease. It 
is possible to argue that such assumptions are purely 
associative, and are not definitive demonstration 
of lesions activity/inactivity status. In this context, 
experimental models appear as a very important 
experimental tool do provide non-mathematical/
non-statistical “biological significance” support to the 
clinical data. The possibility of performing longitudinal 
and controlled analysis, and to implement cause-and-
effect experiments, with the induction or inhibition of 
a given factor (by genetic or pharmacological ways), 
can provide definitive demonstration of such factor 
role in a determined condition. 
Still in the periodontitis activity/inactivity setting, 
experimental periodontitis in mice is characterized by 
sequential stages, where the initial response involves 
a major influx of inflammatory cells, and rapid and 
evident bone resorption and a high RANKL/OPG 
ratio.11,34-36 The subsequent stage is characterized 
by a minor progression of bone loss, a change in the 
pattern of immunoregulatory elements and a low 
RANKL/OPG ratio. The modulation of RANKL/OPG 
ratio, specifically upregulation of OPG by the selective 
attraction of immunoregulatory cells, such as Tregs, 
is associated with the prevention of bone loss.37-
40 Conversely, the inhibition of immunoregulatory 
feedback and the maintenance of high RANKL/OPG 
over time result in increased disease severity.41 Among 
the immunoregulatory elements, IL-10, a potent 
anti-inflammatory molecule which is extensively 
produced by Tregs, was also demonstrated to 
inhibit inflammation and to arrest experimental 
periodontitis progression.18,42-44 Full circle, one of the 
anti-inflammatory mechanisms of IL-10 comprise the 
upregulation of SOCS, which in turn limits the action 
of pro-inflammatory mediators, in parallel with the 
capacity of IL-10 to upregulate OPG. Taken together, 
this experimental data suggests that periodontal 
lesions inactivity may be under the control of IL-
10, which in turn upregulate OPG, induces SOCS 
and consequently limits pro-osteoclastic and pro-
inflammatory activity.32,44,45
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While experimental data does not provide any kind 
of additional “statistical significance” to the associative 
data derived from human studies, including those 
previously mentioned along this essay, the “biological 
significance”, despite being numerically unmeasurable, 
is remarkable. Despite the unprivileged position in the 
scientific evidence pyramid, the “pre-clinical” research 
is essential in unraveling mechanistic evidences for 
biological and pathological processes, and to provide 
the basis for subsequent clinical interventions.46 Mice 
with opposing maximal and minimal inflammatory 
responsiveness genotypes and phenotypes present 
distinct susceptibility/resistance patterns when 
exposed to periodontopathogens, reinforcing the 
genotypic impact over the phenotype unraveled 
under “exposure” conditions,47 PMID.48 The marked 
susceptibility of IL-10 deficient mice to periodontitis 
development43 supported the investigation of genetic 
variants that modulate IL-10 levels in humans,18 
and its role as risk factors for periodontal disease 
development with potential application for diagnosis 
and treatment planning. The possibility of modulating 
the inflammatory environment nature in periodontium 
by IL-10, derived from Tregs recruitment,37-40 was 
demonstrated to the useful in pre-clinical models, 
which support its potential application in future 
clinical trials. The discovery of RANKL/OPG axis in 
experimental models leaded to the development of 
OPG-mimicking/analogues therapeutics currently used 
in humans for diverse bone pathologies.
Finally, we reiterate that this piece (similarly to the 
Amrhein’s Nature assay) are not advocating a ban on P 
values or statistical measures, which remains essential. 
However, it is crucial to consider that statisticians are 
not mystical magical creatures and therefore there are 
no statistical miracles to marvelously overcome poor 
experimental design.
Thus, despite any major change in the way of P 
values or statistical tests are applied and interpreted, 
we must consider that the attention to the proper study 
design may have an immediate and positive influence 
in the numerically unmeasurable data “biological 
significance”.
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